McBride (MCB) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
20 Feb, 2026Executive summary
Achieved strong operational and strategic progress, with volume and profit growth across all divisions.
Revenue grew by £45.8m (up 5.2% year-over-year), reaching £934.8m.
Private label market share increased, with volumes up 7.2% and contract manufacturing gaining momentum.
Net debt reduced by £35.0m, approaching target levels.
Transformation programme and sustainability initiatives advanced, including science-based targets.
Financial highlights
Adjusted operating profit rose to £67.1m from £13.5m, driven by volume growth and margin recovery.
Gross margin improved to 37.2% from 29.7% year-over-year.
Adjusted profit before tax increased to £53.1m from £0.3m.
Adjusted diluted EPS reached 21.7p.
Liquidity at 30 June 2024 was £98.3m, up from £59.3m a year earlier.
Outlook and guidance
Solid start to the new financial year, with volumes in line with expectations.
New product launches and business wins expected to support further growth.
Input costs stable overall, though recycled materials and natural-based chemicals are rising.
Transformation programme implementations planned over the next twelve months.
Lower net debt allows for increased capital investment aligned with strategic priorities.
Latest events from McBride
- FY26 and FY27 adjusted EBITA guidance cut by 5–10% due to input cost pressures; Eurotab deal closing soon.MCB
Trading update - Revenue and profitability rose, driven by private label growth and disciplined cost control.MCB
H1 2026 - Adjusted operating profit on track, with revenue and volume growth supporting future gains.MCB
Trading update - Revenue up, profit steady, cash strong, dividend reinstated, private label at record high.MCB
H2 2025 - Revenue up, net debt down, and contract manufacturing volumes surged 48.9%.MCB
H2 2025 TU - Profit, cash flow, and private label growth enabled dividend plans amid ongoing transformation.MCB
H1 2025